Standout Papers

SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor 1998 2026 2007 2016 588
  1. SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor (1998)
    M Rinaldi-Carmona, Francis Barth et al. Journal of Pharmacology and Experimental Therapeutics

Citation Impact

3 by Nobel laureates 36 from Science/Nature 83 standout
Sub-graph 1 of 21

Citing Papers

Comprehensive Integration of Single-Cell Data
2019 Standout
The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors
2017 StandoutNature
2 intermediate papers

Works of M Portier being referenced

SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor
1998 Standout
gamma-Interferon in multiple myeloma: inhibition of interleukin-6 (IL- 6)-dependent myeloma cell growth and downregulation of IL-6-receptor expression in vitro
1993

Author Peers

Author Hematology Molecular Biology CMN Pharmacology Last Decade Papers Cites
M Portier 268 446 447 647 13 1.3k
Susan A. Mackintosh 32 10 9 410
J. C. Lancaster 2 1 35 407
Dirk Stelzer 1 29 271
Kazuyo Gotoh 17 166 7 4 12 441
Kristin M. Reddoch 210 45 3 4 11 646

All Works

Loading papers...

Rankless by CCL
2026